Compare BridgeBio Pharma Inc (BBIO) vs MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs MONDELEZ INTERNATIONAL INC Common Stock — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while MONDELEZ INTERNATIONAL INC Common Stock trades at $61.51 (market cap $78.85B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 4.8× BridgeBio Pharma Inc's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.24% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | MDLZ | |
|---|---|---|
Market Cap | $16.36B | $78.85B |
Sector | Health | Consumer Staples |
52-Week High | $90.17 | $64.99 |
52-Week Low | $47.29 | $51.51 |
Enterprise Value | $18.14B | $99.19B |
Dividend Yield | — | 3.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About MONDELEZ INTERNATIONAL INC Common Stock
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →
